Polymorphism of CD44 Influences the Efficacy of CD34+ Cells Mobilization in Patients with Hematological Malignancies

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 7, 2014, Pages 986-991

  Szmigielska Kaplon, Anna ^a   Szemraj, Janusz ^a   Hamara, Katarzyna ^a   Robak, Marta ^a   Wolska, Anna ^a   Pluta, Agnieszka ^a   Czemerska, Magdalena ^a   Krawczynska, Anna ^a   Jamroziak, Krzysztof ^a   Szmigielska, Katarzyna ^a   Robak, Tadeusz ^a   Wierzbowska, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

CD44; Mobilization of hematopoietic stem cells; Single nucleotide polymorphism

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; CD44V ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; NAVELBINE; PREDNISONE; VASCULAR CELL ADHESION MOLECULE 1; CD44 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; HERMES ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BODY WEIGHT; CANCER PATIENT; CELL COUNT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GENE FREQUENCY; GENOTYPE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HOMOZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL MOBILIZATION; STEM CELL NICHE; YOUNG ADULT; BIOSYNTHESIS; BLOOD; GENETICS; HEMATOLOGIC DISEASE; PROCEDURES;

ADULT; AGED; ANTIGENS, CD34; ANTIGENS, CD44; BLOOD COMPONENT REMOVAL; FEMALE; GENOTYPE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CXCR4; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 84902081575     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.03.019     Document Type: Article

References (47)

1. Lévesque J.P., Helwani F.M., Winkler I.G. The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization. Leukemia 2010, 24:1979-1992.
2. Winkler I.G., Sims N.A., Pettit A.R., et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010, 116:4815-4828.
3. Arai F., Suda T. Maintenance of quiescent hematopoietic stem cells in osteoblastic niche. Ann N Y Acad Sci 2007, 1106:41-53.
4. Kopp H.G., Avecilla S.T., Hooper A.T., Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 2005, 20:349-356.
5. Colmone A., Sipkins D.A. Beyond angiogenesis: the role of endothelium in the bone marrow vascular niche. Transl Res 2008, 151:1-9.
6. Mohty M., Ho A.D. In and out of the niche: perspectives in mobilization of hematopoietic stem cells. Exp Hematol 2011, 39:723-729.
7. Hooper A.T., Butler J.M., Nolan D.J., et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009, 4:263-274.
8. Moog R. Mobilization and harvesting of peripheral blood stem cells. Curr Stem Cell Res Ther 2006, 1:189-201.
9. Levesque J.P., Winkler I.G. Mobilization of hematopoietic stem cells: state of the art. Curr Opin Organ Transplant 2008, 13:53-58.
10. Vose J.M., Ho A.D., Coiffier B., et al. Advances in mobilization for the optimization of autologous stem cell transplantation. Leuk Lymphoma 2009, 50:1412-1421.
11. Giralt S., Costa L., Schriber J., et al. Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. Biol Blood Marrow Transplant 2014, 20:295-308.
12. Greenbaum A.M., Link D.C. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 2011, 25:211-217.
13. Hoggatt J., Pelus L.M. Many mechanisms mediating mobilization: an alliterative review. Curr Opin Hematol 2011, 18:231-238.
14. Winkler I.G., Pettit A.R., Raggatt L.J., et al. Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation. Leukemia 2012, 26:1594-1601.
15. Liongue C., Wright C., Russell A.P., Ward A.C. Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more. Int J Biochem Cell Biol 2009, 41:2372-2375.
16. Marquez-Curtis L.A., Turner R.A., Sridharan S., et al. The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes. Stem Cell Rev and Rep 2011, 7:590-607.
17. Levesque J.P., Hendy J., Takamatsu Y., et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003, 111:187-196.
18. Kim H.K., De La Luz Sierra M., Williams C.K., et al. G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood 2006, 108:812-820.
19. Benboubker L., Watier H., Carion A., et al. Association between the SDF1-3'A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans. Br J Haematol 2001, 113:247-250.
20. Bogunia-Kubik K., Gieryng A., Dlubek D., Lange A. The CXCL12-3'A allele is associated with a higher mobilization yield of CD34 progenitors to the peripheral blood of healthy donors for allogeneic transplantation. Bone Marrow Transplant 2009, 44:273-278.
21. Lenk J., Bornhauser M., Kramer M., et al. Sex and body mass index but not CXCL12 801 G/A polymorphism determine the efficacy of hematopoietic cell mobilization: a study in healthy volunteer donors. Biol Blood Marrow Transplant 2013, 10:1517-1521.
22. Lee S., Im S.A., Yoo E.S., et al. Mobilization kinetics of CD34(+) cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors. Stem Cells 2000, 18:281-286.
23. Williams K., Motiani K., Giridhar P.V., Kasper S. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches. Exp Biol Med (Maywood) 2013, 238:324-338.
24. Sackstein R. The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives. Curr Opin Hematol 2011, 18:239-248.
25. Vermeulen M., Le Pesteur F., Gagnerault M.C., et al. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 1998, 92:894-900.
26. Zohren F., Toutzaris D., Klärner V., et al. The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans. Blood 2008, 111:3893-3895.
27. Olivieri A., Marchetti M., Lemoli R., et al. Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo. Bone Marrow Transplant 2012, 47:342-351.
28. Martin-Antonio B., Carmona M., Falantes J., et al. Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factors to healthy donors. Hematologica 2011, 96:102-109.
29. Suzuya H., Watanabe T., Nakagawa R., et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang 2005, 89:229-235.
30. Moog R. Management strategies for poor peripheral blood stem cell mobilization. Transfus Apher Sci 2008, 38:229-236.
31. Pusic I., Jiang S.Y., Landua S., et al. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol Blood Marrow Transplant 2008, 14:1045-1056.
32. Jantunen E., Kvalheim G. Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies. Eur J Haematol 2010, 85:463-471.
33. Nowrousian M.R., Waschke S., Bojko P., et al. Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients. Ann Oncol 2003, 14(Suppl 1):i29-i36.
34. Jiang L., Deng J., Zhu X., et al. CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res 2012, 14:R105.
35. Lapid K., Glait-Santar C., Gur-Cohen S., et al. Egress and mobilization of hematopoietic stem and progenitor cells: a dynamic multi-facet process. StemBook [Internet] 2008-2012, Harvard Stem Cell Institute, Cambridge (MA), Available at:. http://www.stembook.org//node/762.
36. Avigdor A., Goichberg P., Shivtiel S., et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004, 103:2981-2989.
37. Stier S., Ko Y., Forkert R., et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005, 201:1781-1791.
38. Khan S.A., Lopez-Chua C.A., Zhang J., et al. Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors. J Cell Biochem 2002, 85:728-736.
39. Wang K.X., Denhardt D.T. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008, 19:333-345.
40. Anborgh P.H., Mutrie J.C., Tuck A.B., Chambers A.F. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med 2010, 14:2037-2044.
41. Ellis S.L., Grassinger J., Jones A., et al. The relationship between bone, hemopoietic stem cells, and vasculature. Blood 2011, 118:1516-1524.
42. Nilsson S.K., Johnston H.M., Whitty G.A., et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005, 106:1232-1239.
43. Szmigielska-Kaplon A., Krawczynska A., Czemerska M., et al. Circulating endothelial cell kinetics and their potential predictive value during mobilization procedure. J Clin Apher 2013, 28:341-348.
44. Szmigielska-Kaplon A., Krawczynska A., Czemerska M., et al. Kinetics and apoptotic profile of circulating endothelial cells in patients undergoing autologous stem cell transplantation. Ann Haematol 2013, 92:1255-1262.
45. Dimitroff C.J., Lee J.Y., Rafii S. CD44 is a major E-selectin ligand on human hematopietic progenitor cells. J Cell Biol 2001, 153:1277-1286.
46. Dagia N.M., Gadhoum S.Z., Knoblauch C.A. G-CSF induced E-selectin ligand expression on human myeloid cells. Nat Med 2006, 12:1185-1190.
47. Salvucci O., Jiang K., Gasperini P., et al. MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1. Haematologica 2012, 97:818-826.